JETIREXPLORE- Search Thousands of research papers



Published in:

Volume 8 Issue 2
February-2021
eISSN: 2349-5162

Unique Identifier

JETIR2102101

Page Number

856-868

Share This Article


Title

CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW

ISSN

2349-5162

Cite This Article

"CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 2, page no.856-868, February-2021, Available :http://www.jetir.org/papers/JETIR2102101.pdf

Abstract

Liposomes are vesicular colloidal carrier system composed of phospholipids bilayer encapsulate aqueous compartments. Since 1960’s liposomes used as therapeutic tools for the delivery of bioactives.Hence number of liposomal formulations available in the market as compare to other carrier system such as nanoparticles,dendrimers etc. The structure and composition of liposomes has a great impact on their properties like biocompatibility,bioactive payload, immuo neutralization,absence of cytotoxicity and hemolytic toxicity. As a result of their unique liposomes are suitable for a wide range of biomedical and industrial applications.The paper gives a concise review of liposomes formulation physico-chemical properties and their clinical application in vaccination, tumor targeting, immunomodulation, topical delivery of bioactives for skin care,gene and antisense therapy. The goal of this review is to provide a short outline of the properties of liposomes and market research analysis of liposomes clinical approved products.

Key Words

Drug delivery; Liposome; Target ligand

Cite This Article

"CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 2, page no. pp856-868, February-2021, Available at : http://www.jetir.org/papers/JETIR2102101.pdf

Publication Details

Published Paper ID: JETIR2102101
Registration ID: 305673
Published In: Volume 8 | Issue 2 | Year February-2021
DOI (Digital Object Identifier):
Page No: 856-868
ISSN Number: 2349-5162

Download Paper

Preview Article

Download Paper




Cite This Article

"CLINICAL APPROVED LIPOSOMAL FORMULATIONS: A OVER VIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 2, page no. pp856-868, February-2021, Available at : http://www.jetir.org/papers/JETIR2102101.pdf




Preview This Article


Downlaod

Click here for Article Preview